-The Times of India NEW DELHI: The government has invoked special powers under the law to prohibit stent makers from withdrawing their products from the market for the next six months. Amid reports that several manufacturers, including Abbott and Medtronic, are seeking to withdraw premium, high-priced Stents from the Indian market on account of the price cap imposed by National Pharmaceutical Pricing Authority (NPPA), the government has directed companies to maintain production,...
More »SEARCH RESULT
Overpriced Stents: NPPA issues notice to two hospitals -Sushmi Dey
-The Times of India NEW DELHI: Promptly addressing complaints against hospitals that were allegedly overcharging for Stents, the National Pharmaceutical Pricing Authority (NPPA) has issued show-cause notices to Max Hospital, Saket (New Delhi), and Nidaan Hospital, Sonipat (Haryana). While the regulator said that the action is based on the findings of its preliminary investigation, both the hospitals denied the charge and maintained that they have "not overcharged a single patient" for Stents. On...
More »NPPA puts price cap on cardiac Stents; says hospitals overcharge -Kundan Pandey
-Down to Earth The average cost of drug eluting stent for domestic companies is around Rs 8,000 but it is sold to patients for Rs 24,000 to Rs 1.5 lakh In a decision that will benefit thousands of people in the country, the National Pharmaceutical Pricing Authority (NPPA) has finally put a ceiling on prices of cardiac stent—a small mesh tube that's used to treat narrow or weak arteries. Cardiac Stents...
More »Govt to sell 439 key drugs at low prices -Sushmi Dey
-The Times of India NEW DELHI: The government is set to expand the coverage of its Jan Aushadhi scheme. It will offer 439 life-saving medicines, including cancer and cardiovascular drugs, as well as 250 medical devices like Stents and implants at 40-50% discounted prices. The department of pharmaceuticals plans to open 300 Jan Aushadhi stores across the country by March and another 3,000 by 2017. Presently, only 45 medicines are available in...
More »Cancer drugs, Stents at 60% discount soon -Sushmi Dey
-The Times of India NEW DELHI: Over 200 cancer drugs, 186 medicines to treat cardiovascular diseases and 148 Stents and cardiac implants will now be available at central government hospitals at prices 50-60% lower than the open market. The health ministry has launched a programme called AMRIT (Affordable Medicines and Reliable Implants for Treatment), under which the government will run pharmacy retail stores to sell medicines in hospitals like All India Institute...
More »